Showing results (201-210 of 216) with videos related to

Sort By:
Pageof 22
The Lancet. Haematology|May 22, 2022
Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trialFeng Xue, Huiyuan Li, Xia Wu, et al.
Cell Stem Cell|February 23, 2021
Hematopoietic Stem Cell Heterogeneity Is Linked to the Initiation and Therapeutic Response of Myeloproliferative NeoplasmsJingyuan Tong, Ting Sun, Shihui Ma, et al.
Blood|July 3, 2025
Marstacimab Prophylaxis in Hemophilia A/B Without Inhibitors: Results from the Phase 3 BASIS TrialDavide Matino, Andrew Palladino, Carrie Turich Taylor, et al.
Blood|January 15, 2026
Single-Cell Profiling of ANKRD26 Thrombocytopenia Reveals Progenitor Expansion and Polyploid Apoptosis via JUNB-p21Lin Chen, Lanyue Hu, Xiaofan Liu, et al.
British Journal of Haematology|November 15, 2023
Characteristics and outcomes of COVID-19 in Chinese immune thrombocytopenia patients: A prospective cohort studyYunfei Chen, Jiaying Liu, Shuai Shao, et al.
Journal of Thrombosis and Haemostasis : JTH|August 15, 2024
Novel GPIb-independent platelet aggregation induced by botrocetin: implications for diagnosis and antithrombotic therapyChuanbin Shen, Daniel T Mackeigan, Aron A Shoara, et al.
Annals of Hematology|June 6, 2024
Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trialHeng Mei, Xiaofan Liu, Yan Li, et al.
Blood Science (Baltimore, Md.)|November 3, 2025
Chinese guidance for the clinical application of adeno-associated virus vector-based gene therapy for hemophilia B (2025)Feng Xue, Yu Hu, Renchi Yang, et al.
Research and Practice in Thrombosis and Haemostasis|December 10, 2025
Hetrombopag for patients with persistent primary immune thrombocytopenia: a post hoc analysis of a multicenter, randomized phase Ⅲ trialHeng Mei, Xiaofan Liu, Yan Li, et al.
British Journal of Haematology|June 15, 2026
Long-term outcomes with emicizumab prophylaxis for haemophilia A in China: A multicentre, large-cohort retrospective studyYuan Xu, Ying Wang, Ningling Wang, et al.
Pageof 22